AR and neoplasm: To evaluate the potential tumor-suppressive effect of ZBTB10 in downregulating PKLR-driven PCa progression, we used a stable ZBTB10-expressing clone and compared it to ZBTB10-expressing cells rescued with the PKLR cDNA vector in AR-positive LNCaP and C4-2 cells.